In addition, Sema3A is considered to function as a tumor suppressor as reduced Sema3A expression is correlated with breast carcinoma and melanoma progression in humans [17, 19], while overexpression of Sema3A suppresses tumor growth and metastasis in vivo using xenograft mouse models [16–18]. Here, SEMA3A is linked to breast carcinoma.